Search clinical trials for: Alimta (Pemetrexed)
Total 1209 results
-
University of PittsburghNovartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States
-
Si-Yu WangCompleted
-
PfizerCompletedCarcinoma, Non-Small Cell LungUnited States, Ukraine, Poland, Russian Federation, Taiwan, Italy, Spain, United Kingdom, Romania, Switzerland, Japan
-
Accelerated Community Oncology Research NetworkEli Lilly and Company; Genentech, Inc.CompletedNon-Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedHead and Neck CancerUnited States
-
University of UtahAstraZenecaRecruitingNon-Small Cell Lung Cancer MetastaticUnited States
-
University of PittsburghBristol-Myers Squibb; Eli Lilly and CompanyCompletedHead and Neck CancerUnited States
-
Eli Lilly and CompanyGenentech, Inc.Completed
-
Christiana Care Health ServicesEli Lilly and CompanyCompletedNon Small Cell Lung Cancer
-
Eli Lilly and CompanyTerminatedLung NeoplasmsBrazil, United States, India
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Dana-Farber Cancer InstituteBrigham and Women's HospitalTerminatedMalignant Pleural Mesothelioma | Pleural MesotheliomaUnited States
-
University of ArizonaNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity CancerUnited States
-
Chang Gung Memorial HospitalTaiwan Chest Disease AssociationCompletedAdvanced Non-Squamous Non-Small Cell Lung CancerTaiwan
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
Lantern Pharma Inc.RecruitingCarcinoma, Non-Small-Cell Lung | Adenocarcinoma of LungUnited States
-
The Netherlands Cancer InstitutePfizerCompletedMalignant Pleural MesotheliomaNetherlands
-
Eli Lilly and CompanyCompletedHead and Neck NeoplasmsUnited States
-
Novartis PharmaceuticalsTerminatedAdvanced Non Small Cell Lung Cancer (NSCLC)France, Italy, Taiwan, Spain, Netherlands, Japan, Hong Kong, Korea, Republic of, Norway, United States, United Kingdom, Poland
-
M.D. Anderson Cancer CenterRecruitingMetastatic Cancer | Urothelial CarcinomaUnited States
-
Hoffmann-La RocheCompletedNon-small Cell Lung CancerBelgium, Italy, Portugal, Spain, Germany, Turkey, France, Hong Kong, Korea, Republic of, Poland, Russian Federation, Hungary, Norway, Bulgaria, Slovakia
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompletedNon Small Cell Lung CancerGreece
-
Julia K. Rotow, MDInivataActive, not recruitingMetastatic Non-Small Cell Lung Cancer | NSCLC Stage IVUnited States
-
Virginia Commonwealth UniversityNational Cancer Institute (NCI)CompletedUnspecified Adult Solid TumorUnited States
-
iTeos Belgium SARecruitingMetastatic NSCLC - Non-Small Cell Lung Cancer | Locally Advanced NSCLC - Non-Small Cell Lung CancerUnited Kingdom, Spain, Belgium, France, United States, Switzerland, Italy, Germany, Canada, Czechia, Poland
-
Bristol-Myers SquibbTerminatedSafety and Efficacy Trial of Ipilimumab Versus Pemetrexed in Non-Squamous Non-Small Cell Lung CancerLung Cancer - Non Small CellUnited States, Belgium, France, Germany, Spain
-
Eli Lilly and CompanyUniversity of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaboratorsCompletedNon Small Cell Lung CancerBelgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
-
Hangzhou ACEA Pharmaceutical Research Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesWithdrawn
-
The Netherlands Cancer InstituteWithdrawnNon-Small Cell Lung Cancer
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedMetastatic Urothelial CarcinomaUnited States
-
PfizerCompleted
-
Guangzhou Medical UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Eli Lilly and CompanyCompleted
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Effector TherapeuticsMedpace, Inc.; ICON plcActive, not recruitingNon-small Cell Lung CancerUnited States, Australia, Georgia
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer
-
National Cancer Institute (NCI)WithdrawnAMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural MesotheliomaRecurrent Malignant Mesothelioma | Advanced Malignant Mesothelioma | Epithelial Mesothelioma | Sarcomatous Mesothelioma
-
Merck Sharp & Dohme LLCCompleted
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerUnited Kingdom, Germany, Poland, Belgium, Spain, Italy, Greece, Australia, Netherlands, Romania, France, India, Finland, Turkey, Portugal
-
Chonnam National University HospitalSanofiTerminatedCarcinoma, Non Small Cell LungKorea, Republic of
-
Heat BiologicsCompletedNon-small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompleted
-
Liza Villaruz, MDGenentech, Inc.RecruitingNon-small Cell Lung CancerUnited States
-
OSE ImmunotherapeuticsTerminatedNon Small Cell Lung CancerFrance, Spain, Israel, United States, United Kingdom, Italy, Poland, Czechia, Germany, Hungary
-
Christopher Sweeney, MBBSEli Lilly and Company; Walther Cancer InstituteCompletedProstate CancerUnited States
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerUnited States, Canada
-
Aduro Biotech, Inc.CompletedMalignant Pleural MesotheliomaUnited States